APA (7th ed.) Citation

NR, R., O, D., T, N., S, L., TJ, H., JC, D., . . . JN, S. (2024). Levetiracetam prevents Aβ42 production through SV2a-dependent modulation of App processing in Alzheimer's disease models. BioRxiv : the preprint server for biology. https://doi.org/10.1101/2024.10.28.620698

Chicago Style (17th ed.) Citation

NR, Rao, et al. "Levetiracetam Prevents Aβ42 Production Through SV2a-dependent Modulation of App Processing in Alzheimer's Disease Models." BioRxiv : The Preprint Server for Biology 2024. https://doi.org/10.1101/2024.10.28.620698.

MLA (9th ed.) Citation

NR, Rao, et al. "Levetiracetam Prevents Aβ42 Production Through SV2a-dependent Modulation of App Processing in Alzheimer's Disease Models." BioRxiv : The Preprint Server for Biology, 2024, https://doi.org/10.1101/2024.10.28.620698.